Page 1 of Clinical Trials for Chelsea Therapeutics [SPONSOR-COLLABORATORS], 16 Total Matches
- 1CompletedLast Updated: May 8, 2012Condition(s): Attention Deficit Hyperactivity Disorder
- 2Not yet recruitingLast Updated: March 6, 2012Condition(s): Gait Disorders, Neurologic
- 3Enrolling by invitationLast Updated: January 26, 2012Condition(s): Primary Autonomic Failure; Dopamine Beta Hydroxylase Deficiency; Non-Diabetic Neuropathy; Neurogenic Orthostatic Hypotension
- 4CompletedLast Updated: October 11, 2010Condition(s): Symptomatic Neurogenic Orthostatic Hypotension
- 5CompletedLast Updated: January 25, 2012Condition(s): Symptomatic Neurogenic Orthostatic Hypotension (NOH); Non-diabetic Neuropathy; Primary Autonomic Failure; Dopamine Beta Hydroxylase Deficiency
- 6RecruitingLast Updated: March 9, 2012Condition(s): Orthostatic Hypotension; Parkinson's Disease
- 7Active, not recruitingLast Updated: March 22, 2012Condition(s): Rheumatoid Arthritis
- 8CompletedLast Updated: July 30, 2010Condition(s): Intradialytic Hypotension
- 9CompletedLast Updated: June 20, 2011Condition(s): Arthritis, Rheumatoid
- 10Not yet recruitingLast Updated: March 7, 2012Condition(s): Renal Disease; End Stage Renal Disease
- 11CompletedLast Updated: January 25, 2012Condition(s): Symptomatic Neurogenic Orthostatic Hypotension (NOH); Non-diabetic Neuropathy; Primary Autonomic Failure; Dopamine Beta Hydroxylase Deficiency
- 12CompletedLast Updated: March 6, 2012Condition(s): QTc Interval
- 13TerminatedLast Updated: May 8, 2012Condition(s): Chronic Fatigue Syndrome; Orthostatic Hypotension; Neurally Mediated Hypotension; Neurogenic Orthostatic Hypotension
- 14CompletedLast Updated: November 14, 2011Condition(s): Fibromyalgia
- 15CompletedLast Updated: January 25, 2012Condition(s): Symptomatic Neurogenic Orthostatic Hypotension (NOH); Non-diabetic Neuropathy; Primary Autonomic Failure; Dopamine Beta Hydroxylase Deficiency
- 16RecruitingLast Updated: May 13, 2011Condition(s): Spinal Cord Injury; Hypotension
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Chelsea+Therapeutics
